Backs FY26 adjusted EBITDA margin view 12.5%-13%. Backs FY26 free cash flow view EUR 1.3B-1.5B. The company said, “Philips (PHG) 2026 outlook includes currently known information, including tariffs, within an uncertain macro environment. It excludes any potential International Emergency Economic Powers Act tariff refunds. It excludes ongoing Philips Respironics-related proceedings, including the investigation by the US Department of Justice.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips Starts 2026 with Solid Q1 Growth, Margin Expansion and Renewed Outlook
- Hold Rating Reaffirmed as Mixed Segment Performance and Valuation Keep Risk/Reward Balanced; Price Target Cut from $28 to $27
- Is PHG a Buy, Before Earnings?
- Philips receives FDA clearance for Rembra platform
- Philips receives FDA 510(k) clearance for Verida system